Loading…
Reported covered position: Senior Policy Advisor, Office of House Republican Leader Kevin McCarthy; Deputy Health Policy Director, Senate Finance Committee; Health Policy Advisor, Senator Orrin Hatch; Sr. LA, Congressman Erik Paulsen; LA, Congressman Jeff Fortenberry
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Ensuring Patient Access to Critical Breakthrough Products Act
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Ensuring Patient Access to Critical Breakthrough Products Act
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NOVOCURE INC. via NOVOCURE INC.
2026 · third_quarter · Q3
Tariff issues, specifically related to medical device 232.
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
Source: Senate LDA
Ensuring Patient Access to Critical Breakthrough Products Act
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Ensuring Patient Access to Critical Breakthrough Products Act
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Ensuring Patient Access to Critical Breakthrough Products Act
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.1691/S.5349 - Ensuring Patient Access to Critical Breakthrough Products Act of 2024.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.1691/S.5349 - Ensuring Patient Access to Critical Breakthrough Products Act of 2024.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.1691/S.5349 - Ensuring Patient Access to Critical Breakthrough Products Act of 2024.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.1691/S.5349 - Ensuring Patient Access to Critical Breakthrough Products Act of 2024.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare / Medicaid Issues. H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Ensuring Patient Access to Critical Breakthrough Products Act of 2021
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare / Medicaid Issues. H.R.4043 - Ensuring Patient Access to Critical Breakthrough Products Act of 2021.
Ensuring Patient Access to Critical Breakthrough Products Act of 2021
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare / Medicaid Issues. H.R.4043 - Ensuring Patient Access to Critical Breakthrough Products Act of 2021.
Ensuring Patient Access to Critical Breakthrough Products Act of 2021
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare / Medicaid Issues. H.R.4043 - Ensuring Patient Access to Critical Breakthrough Products Act of 2021.
Ensuring Patient Access to Critical Breakthrough Products Act of 2021
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare / Medicaid Issues. H.R.4043 - Ensuring Patient Access to Critical Breakthrough Products Act of 2021.
Ensuring Patient Access to Critical Breakthrough Products Act of 2021
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare / Medicaid Issues. H.R.4043 - Ensuring Patient Access to Critical Breakthrough Products Act of 2021.
2026 · second_quarter · Q2
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Tariff issues, specifically related to medical device 232.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
NOVOCURE INC. via NOVOCURE INC.
2026 · first_quarter · Q1
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Tariff issues, specifically related to medical device 232.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVOCURE INC. via NOVOCURE INC.
2025 · fourth_quarter · Q4
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Tariff issues, specifically related to medical device 232.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVOCURE INC. via NOVOCURE INC.
2025 · third_quarter · Q3
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVOCURE INC. via NOVOCURE INC.
2025 · second_quarter · Q2
General Medicare Issues. S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Veterans Affairs / Veterans Health Administration (VHA) issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVOCURE INC. via NOVOCURE INC.
2025 · first_quarter · Q1
General Medicare Issues. H.R.1691/S.5349 - Ensuring Patient Access to Critical Breakthrough Products Act of 2024.
Veterans Affairs / Veterans Health Administration (VHA) issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVOCURE INC. via NOVOCURE INC.
2024 · fourth_quarter · Q4
General Medicare Issues. H.R.1691/S.5349 - Ensuring Patient Access to Critical Breakthrough Products Act of 2024.
Veterans Affairs / Veterans Health Administration (VHA) issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVOCURE INC. via NOVOCURE INC.
2024 · third_quarter · Q3
Veterans Affairs / Veterans Health Administration (VHA) issues.
General Medicare Issues. H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVOCURE INC. via NOVOCURE INC.
2024 · second_quarter · Q2
Veterans Affairs / Veterans Health Administration (VHA) issues.
General Medicare Issues. H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVOCURE INC. via NOVOCURE INC.
2024 · first_quarter · Q1
General Medicare Issues. H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Veterans Affairs / Veterans Health Administration (VHA) issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVOCURE INC. via NOVOCURE INC.
2023 · fourth_quarter · Q4
General Medicare Issues. H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Veterans Affairs / Veterans Health Administration (VHA) issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVOCURE INC. via NOVOCURE INC.
2023 · third_quarter · Q3
General Medicare Issues. H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVOCURE INC. via NOVOCURE INC.
2023 · second_quarter · 2A
TSA Issues.
Veteran Affairs Issues.
General Medicare Issues. H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, Transportation Security Administration (TSA), White House Office
NOVOCURE INC. via NOVOCURE INC.
2023 · second_quarter · Q2
TSA Issues.
General Medicare Issues. H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Veteran Affairs Issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, Transportation Security Administration (TSA), White House Office
NOVOCURE INC. via NOVOCURE INC.
2023 · first_quarter · Q1
TSA Issues.
Veteran Affairs Issues.
General Medicare / Medicaid Issues. H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Transportation Security Administration (TSA), White House Office
NOVOCURE INC. via NOVOCURE INC.
2022 · fourth_quarter · 4A
TSA Issues.
General Medicare / Medicaid Issues. H.R.4043 - Ensuring Patient Access to Critical Breakthrough Products Act of 2021.
Veteran Affairs Issues.
Filing targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Transportation Security Administration (TSA), White House Office
NOVOCURE INC. via NOVOCURE INC.
2022 · fourth_quarter · Q4
General Medicare / Medicaid Issues. H.R.4043 - Ensuring Patient Access to Critical Breakthrough Products Act of 2021.
Veteran Affairs Issues.
TSA Issues.
Filing targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Transportation Security Administration (TSA), White House Office
NOVOCURE INC. via NOVOCURE INC.
2022 · third_quarter · Q3
General Medicare / Medicaid Issues. H.R.4043 - Ensuring Patient Access to Critical Breakthrough Products Act of 2021.
Veteran Affairs Issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE, White House Office
NOVOCURE INC. via NOVOCURE INC.
2022 · second_quarter · Q2
Veteran Affairs Issues.
General Medicare / Medicaid Issues. H.R.4043 - Ensuring Patient Access to Critical Breakthrough Products Act of 2021.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE
NOVOCURE INC. via NOVOCURE INC.
2022 · first_quarter · Q1
General Medicare / Medicaid Issues. H.R.4043 - Ensuring Patient Access to Critical Breakthrough Products Act of 2021.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVOCURE INC. via NOVOCURE INC.
2022 · first_quarter · RR
General Medicare / Medicaid Issues